[go: up one dir, main page]

RU2002117537A - A method for treating the effects of tissue hypoxia in critically ill patients - Google Patents

A method for treating the effects of tissue hypoxia in critically ill patients

Info

Publication number
RU2002117537A
RU2002117537A RU2002117537/14A RU2002117537A RU2002117537A RU 2002117537 A RU2002117537 A RU 2002117537A RU 2002117537/14 A RU2002117537/14 A RU 2002117537/14A RU 2002117537 A RU2002117537 A RU 2002117537A RU 2002117537 A RU2002117537 A RU 2002117537A
Authority
RU
Russia
Prior art keywords
treating
effects
critically ill
ill patients
tissue hypoxia
Prior art date
Application number
RU2002117537/14A
Other languages
Russian (ru)
Other versions
RU2226096C1 (en
Inventor
Георгий Александрович Ливанов
Виктор Васильевич Мороз
Баир Васильевич Батоциренов
Андрей Юрьевич Андрианов
Original Assignee
Санкт-Петербургский государственный научно-исследовательский институт скорой помощи им. И.И. Джанелидзе
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санкт-Петербургский государственный научно-исследовательский институт скорой помощи им. И.И. Джанелидзе filed Critical Санкт-Петербургский государственный научно-исследовательский институт скорой помощи им. И.И. Джанелидзе
Priority to RU2002117537/14A priority Critical patent/RU2226096C1/en
Publication of RU2002117537A publication Critical patent/RU2002117537A/en
Application granted granted Critical
Publication of RU2226096C1 publication Critical patent/RU2226096C1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (1)

Способ лечения последствий тканевой гипоксии у пациентов в критическом состоянии, основанный на инфузионном введении реамберина, отличающийся тем, что за 1 час до инфузии реамберина вводят перфторан в дозе 5-7 мл/кг массы тела однодвухкратно с периодичностью в 24 ч.A method for treating the effects of tissue hypoxia in critically ill patients, based on the infusion of reamberin, characterized in that 1 hour before the infusion of reamberin, perftoran is administered at a dose of 5-7 ml / kg of body weight once twice with a frequency of 24 hours.
RU2002117537/14A 2002-07-01 2002-07-01 Method for treating hypoxia consequences in patients in critical state RU2226096C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002117537/14A RU2226096C1 (en) 2002-07-01 2002-07-01 Method for treating hypoxia consequences in patients in critical state

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002117537/14A RU2226096C1 (en) 2002-07-01 2002-07-01 Method for treating hypoxia consequences in patients in critical state

Publications (2)

Publication Number Publication Date
RU2002117537A true RU2002117537A (en) 2004-02-10
RU2226096C1 RU2226096C1 (en) 2004-03-27

Family

ID=32390520

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002117537/14A RU2226096C1 (en) 2002-07-01 2002-07-01 Method for treating hypoxia consequences in patients in critical state

Country Status (1)

Country Link
RU (1) RU2226096C1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL373780A1 (en) 2002-02-25 2005-09-19 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
RU2277412C2 (en) * 2004-05-31 2006-06-10 Муниципальное учреждение здравоохранения больница №11 (МУЗ больница №11) Method for preventing reperfusion complications in tourniquet trauma cases
RU2269348C1 (en) * 2004-10-19 2006-02-10 Кировская государственная медицинская академия (КГМА) Method for protecting ischemized liver
RU2292880C2 (en) * 2004-10-21 2007-02-10 ГУ Научно-исследовательский институт общей реаниматологии РАМН Method for monitoring postpartum period in heavy gestosis cases
RU2289395C2 (en) * 2004-11-05 2006-12-20 Муниципальное учреждение здравоохранения Городская клиническая больница №3 им. М.А. Подгорбунского (МУЗ ГКБ №3) Method for treating heavy compression injury of soft tissues
CN104840455A (en) 2005-02-24 2015-08-19 扩散药品有限公司 Trans carotenoids, their synthesis, formulation and uses
BRPI0810647A2 (en) 2007-04-13 2014-11-04 Diffusion Pharmaceuticals Llc "Use of Bipolar Trans Carotenoids as a Pretreatment and in the Treatment of Peripheral Vascular Disease".
KR101875843B1 (en) 2009-06-22 2018-07-06 디퓨젼 파마슈티컬즈 엘엘씨 Diffusion enhancing compounds and their use alone or with thrombolytics
AU2011262361A1 (en) 2010-06-02 2013-01-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
EP3432929A4 (en) 2016-03-24 2019-11-27 Diffusion Pharmaceuticals LLC USE OF BIPOLAR TRANS-CAROTENOIDS WITH CHEMOTHERAPY AND RADIATION THERAPY FOR THE TREATMENT OF CANCER

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2144817C1 (en) * 1996-07-12 2000-01-27 Левитан Болеслав Наумович Method of treatment of patient with acute intoxication

Also Published As

Publication number Publication date
RU2226096C1 (en) 2004-03-27

Similar Documents

Publication Publication Date Title
MXPA05007857A (en) Indole-derivative modulators of steroid hormone nuclear receptors.
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
CZ176495A3 (en) The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes
AU1249902A (en) Effective antitumour treatments
RU2002117537A (en) A method for treating the effects of tissue hypoxia in critically ill patients
EA200400548A1 (en) TREATMENT OF HEAVY PNEUMONIA THROUGH THE INTRODUCTION OF THE TISSUE FACTOR INHIBITOR (TFPI)
NZ507203A (en) Use of dexmedetomidine for ICU sedation
EP1440689A3 (en) Treatment of neurotic disorders
EP1561462A3 (en) Anti arrhytmic composition and methods of treatment
BR0009380A (en) Improved cancer treatment with temozozomide
MD2549F1 (en) Method of treatment of the chronic viral hepatitis C
FI20011464A0 (en) Combination therapy for the treatment of heart failure
FI20020197A0 (en) A combination treatment method for acute myocardial infarction
RU2004112422A (en) ROUVASTATIN IN PREDEDENTIONAL CONDITIONS
WO2004096141A3 (en) Method for promoting uninterrupted sleep by administration of trospium chloride
DE60111622D1 (en) ISOLATED DOSE THERAPIES WITH VULNERABLE ACTIVITY
WO2001007038A3 (en) Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy
NZ542305A (en) Treatment of proliferative diseases with an epothilone derivative and radiation
WO2003072019A3 (en) Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
FI20010233A0 (en) A method for treating heart failure
RU2003121780A (en) METHOD FOR CORRECTION OF MICRO-CIRCULATION DISORDERS IN PATIENTS WITH THERMAL INJURY
RU2000110690A (en) METHOD OF ANTIBIOTIC THERAPY
MD1780F1 (en) Method of treatment of patients with hepatic cirrhosis
AU2003288107A1 (en) Tiotropium-containing medicament combinations used for inhaling
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20040702